LAM
IPXL

Lebenthal Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Lebenthal Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-111
Closed -$3K – 795
2016
Q3 		$3K Buy
+111
New +$2.98K ﹤0.01% 926

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lebenthal Asset Management's IPXL Position: Q4 2016 in Review

Lebenthal Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 111 shares — an estimated $3K sold.

Lebenthal Asset Management first reported a position in IPXL in Q3 2016 and held it in 1 quarter. The position peaked at $3K in Q3 2016. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

  • Lebenthal Asset Management reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
  • Lebenthal Asset Management sold 111 Impax Laboratories, Inc. shares in Q4 2016, an estimated $3K.
  • Lebenthal Asset Management first reported a position in Impax Laboratories, Inc. in Q3 2016 and held it in 1 quarter.
  • Lebenthal Asset Management's Impax Laboratories, Inc. position peaked at $3K in Q3 2016.
  • 198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Lebenthal Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.